Barclays
LFST icon

Barclays’s Lifestance Health LFST Stock Holding History

Barclays’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6M Sell
2,765,692
-709,803
-20% -$4.94M ﹤0.01% 1160
2025
Q4 		$24.5M Sell
3,475,495
-33,057
-0.9% -$199K 0.01% 1138
2025
Q3 		$19.3M Buy
3,508,552
+1,499,687
+75% +$7.35M ﹤0.01% 1251
2025
Q2 		$10.4M Buy
2,008,865
+581,732
+41% +$3.49M ﹤0.01% 1557
2025
Q1 		$9.5M Buy
1,427,133
+130,445
+10% +$992K ﹤0.01% 1444
2024
Q4 		$9.56M Buy
1,296,688
+27,784
+2% +$199K ﹤0.01% 1609
2024
Q3 		$8.88M Buy
1,268,904
+1,189,594
+1,500% +$7.15M ﹤0.01% 1569
2024
Q2 		$389K Sell
79,310
-32,699
-29% -$197K ﹤0.01% 3197
2024
Q1 		$691K Sell
112,009
-67,454
-38% -$454K ﹤0.01% 3377
2023
Q4 		$1.41M Buy
179,463
+131,902
+277% +$850K ﹤0.01% 3196
2023
Q3 		$327K Buy
47,561
+12,858
+37% +$104K ﹤0.01% 3046
2023
Q2 		$317K Sell
34,703
-1,986
-5% -$16.5K ﹤0.01% 3009
2023
Q1 		$273K Buy
36,689
+17,288
+89% +$95.9K ﹤0.01% 3630
2022
Q4 		$95.8K Buy
19,401
+16,337
+533% +$101K ﹤0.01% 4250
2022
Q3 		$20K Sell
3,064
-13,417
-81% -$93.6K ﹤0.01% 4063
2022
Q2 		$91K Sell
16,481
-3,830
-19% -$29.3K ﹤0.01% 3807
2022
Q1 		$205K Buy
+20,311
New +$178K ﹤0.01% 3417

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Barclays's LFST Position: Q1 2026 in Review

Barclays reduced its Lifestance Health (LFST) stake by 20% in Q1 2026, selling an estimated $4.94M and leaving 2,765,692 shares worth $17.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

Barclays first reported a position in LFST in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.5M in Q4 2025. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Barclays held 2,765,692 shares of Lifestance Health worth $17.6M as of Q1 2026.
  • Barclays sold 709,803 Lifestance Health shares in Q1 2026, an estimated $4.94M.
  • Lifestance Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1160 holding.
  • Barclays first reported a position in Lifestance Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Lifestance Health position peaked at $24.5M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.